Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

MKP Capital Management announces principal appointments and sale of passive, minority interest

Tuesday, January 08, 2013
Opalesque Industry Update: MKP Capital Management, L.L.C., a diversified alternative asset manager, today announced the promotions of Jason Bonanca, Head of Strategy and Research, Henry Lee, Chief Risk Officer, and Richard Lightburn, Senior Portfolio Manager, from Partners to Managing Members. All three new Members have been long-term contributors to MKP’s management team. The formal elevation of Messrs. Bonanca, Lee and Lightburn is a part of MKP’s long-term strategy to build and secure the next generation of leadership that will enhance the Firm’s foundation and future growth.

“MKP’s long-term approach includes a formal process to cultivate, mentor and elevate the next generation of leaders,” said Patrick McMahon, MKP’s Founder and CEO. “This process has resulted in the development of a stronger leadership team at MKP. Jason, Henry and Richard’s appointments reinforce our efforts to build a world class investment management firm.”

The three new Managing Members join existing Members: Mr. McMahon, Anthony Lembke, Co-Chief Investment Officer, and Thomas DeVita, Chief Operating Officer and Chief Financial Officer.

MKP also announced the sale of a passive, non-voting, minority stake in the Firm to Dyal Capital Partners, a permanent capital vehicle affiliated with Neuberger Berman Group LLC. This new relationship, coupled with the elevation of new Members, allows MKP to broaden employee ownership and long-term leadership, as well as develop stronger relationships with Dyal’s institutional clients.

“Partnering with MKP aligns Dyal with what we view as one of today’s preeminent hedge fund managers,” Michael Rees, Senior Portfolio Manager for Dyal Capital Partners, said. “We believe that MKP has become best-in-class because of their highly experienced management team, their 17-year track record and the diversity of their product platform. We look forward to a long-termrelationship of continued success.”

As part of thetransaction, the after-tax proceeds have been reinvested in MKP’s three commingled strategies.

Dyal Capital Partners has no control on the investment process or day-to-day operations at MKP.

The terms of the transaction were not disclosed. MKP was advised by Schulte Roth & Zabel LLP. Dyal was advised by Fried, Frank, Harris, Shriver & Jacobson LLP.

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for